Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs Transparent Meds

BetterMe Rx
Graded #230

Higher grade

vs+3.000000000000007
Transparent Meds
Graded #282

Lower grade

The verdict

BetterMe Rx takes it — 64.9/100 to 61.9/100.

BetterMe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBetterMe Rx +1
44
43
Dose & formulationTransparent Meds +2
75
77
Clinical oversightBetterMe Rx +5
84
79
Labs & monitoringEven
52
52
FulfillmentBetterMe Rx +14
88
74
Contract termsBetterMe Rx +6
47
41
BetterMe Rx · left barTransparent Meds · right bar

The numbers

MetricBetterMe RxTransparent Meds
WeighScore64.9/10061.9/100
GradeCC
Scorecard rank#230#282
Semaglutide$199/mo (promotional rate, compounded)$229/mo (promotional rate, compounded)
Tirzepatide$299/mo (promotional rate, compounded)$349/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
BetterMe Rx

Graded #230 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Transparent Meds

Graded #282 · C

Strengths

  • Transparent, upfront monthly pricing — intro $149/mo for compounded semaglutide and $249/mo for tirzepatide (regular $229 / $349)
  • Clean, modern telehealth experience with a quick eligibility quiz and clinician review before any prescription
  • HIPAA-compliant and displays a LegitScript-style verification seal

Where it loses points

  • Headline prices are intro first-month fees — the regular monthly cost is higher ($229 semaglutide, $349 tirzepatide)
  • Connector model that pairs you with licensed providers; it doesn't name its compounding pharmacy
  • Doesn't publish the states it serves, so confirm availability before signing up
  • Compounded semaglutide and tirzepatide injections only — no oral, brand-name, or insurance options

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard